The evolving role of 131I for the treatment of differentiated thyroid carcinoma
RJ Robbins, MJ Schlumberger - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The use of radioactive iodine (131 I) for the treatment of thyroid carcinoma has changed over
the past 50 y. These changes are based on increasing awareness of the biophysical …
the past 50 y. These changes are based on increasing awareness of the biophysical …
The changing role of radioiodine in the management of differentiated thyroid cancer
JC Reynolds, J Robbins - Seminars in nuclear medicine, 1997 - Elsevier
This article discusses several aspects of the evaluation and management of differentiated
thyroid carcinoma that are changing or may change in the near future. Although …
thyroid carcinoma that are changing or may change in the near future. Although …
The treatment of thyroid carcinoma with radioactive iodine
WH Beierwaltes - Seminars in Nuclear Medicine, 1978 - Elsevier
Radioiodine (131 I) treatment of well-differentiated thyroid carcinoma is a well-evaluated
therapeutic model for nuclear medicine which has never been equaled by subsequent …
therapeutic model for nuclear medicine which has never been equaled by subsequent …
[PDF][PDF] Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma
DL Bushnell, MA Boles, GE Kaufman… - Journal of Nuclear …, 1992 - Soc Nuclear Med
Nuclear Medicine Service and Medical Service, Hines Veterans Affairs Hospital, Hines,
Illinois; and Division of Nuclear Medicine, Department ofRadiology, and Department …
Illinois; and Division of Nuclear Medicine, Department ofRadiology, and Department …
Radio-iodine therapy in differentiated thyroid cancer: indications and procedures
C Reiners, M Dietlein, M Luster - Best Practice & Research Clinical …, 2008 - Elsevier
Post-surgical ablative iodine-131 therapy is recommended for all differentiated thyroid
cancer primary tumors> 1cm in diameter. Regarding smaller primary tumors, 131I ablation …
cancer primary tumors> 1cm in diameter. Regarding smaller primary tumors, 131I ablation …
Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy
KL Parthasarathy, ES Crawford - Journal of Nuclear Medicine …, 2002 - Soc Nuclear Med
There is an abundance of evidence indicating that the oral administration of sodium 13II-
iodide is of value in the management of well-differentiated thyroid cancers. The first step in …
iodide is of value in the management of well-differentiated thyroid cancers. The first step in …
(131) I therapy of thyroid cancer patients
C Reiners, J Farahati - The Quarterly Journal of Nuclear …, 1999 - search.proquest.com
Thyroid cancer is a rare malignancy with wide interethnic and geographic variations. In
Germany thyroid carcinoma is the 13th most frequent malignancy (2.7 new cases yearly per …
Germany thyroid carcinoma is the 13th most frequent malignancy (2.7 new cases yearly per …
Radioiodine therapy for thyroid cancer
DC Sweeney, GS Johnston - … and metabolism clinics of North America, 1995 - Elsevier
Radioiodine-131 has attained a significant role in the treatment of differentiated thyroid
cancer. The most favorable outcome can be expected when iodine-131 is used in …
cancer. The most favorable outcome can be expected when iodine-131 is used in …
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.
HR Maxon 3rd, EE Englaro, SR Thomas… - Journal of nuclear …, 1992 - europepmc.org
For almost five decades, 131I treatment of thyroid cancer has been based empirically on
administered activity rather than on actual radiation doses delivered. In 1983, we defined …
administered activity rather than on actual radiation doses delivered. In 1983, we defined …
Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I
JC Sisson, BL Shulkin, S Lawson - Journal of Nuclear Medicine, 2003 - Soc Nuclear Med
There is no consensus on the amount of 131I for treatment of patients with well-differentiated
thyroid carcinoma; usual amounts vary widely. Body retention of 131I has been shown to be …
thyroid carcinoma; usual amounts vary widely. Body retention of 131I has been shown to be …